{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/leveraging-community-based-clinical-trial-sites-expand-oncology-research-access#webpage",
"url": "https://www.fortrea.com/insights/leveraging-community-based-clinical-trial-sites-expand-oncology-research-access",
"name": "Intelligent innovation at Fortrea: How AI is transforming clinical research",
"description": "Explore how community-based oncology trials and the integration of community and regional sites are improving access to oncology clinical trials and expanding research reach. Learn how expanding clinical trial site networks in oncology supports diversity and equity in oncology clinical trials by bringing studies closer to patients. Explore how integrating community sites in clinical trials helps reduce patient burden, improve participation, and enhance overall trial accessibility. Learn how oncology clinical trial site solutions enable better patient access and strengthen oncology research access across underserved populations. By focusing on community engagement, site expansion, and equitable access, organizations can improve inclusion and drive more representative oncology clinical trial outcomes."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Leveraging community-based clinical trial sites to expand oncology research access",
"item": "https://www.fortrea.com/insights/leveraging-community-based-clinical-trial-sites-expand-oncology-research-access"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry - as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/leveraging-community-based-clinical-trial-sites-expand-oncology-research-access#article",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/leveraging-community-based-clinical-trial-sites-expand-oncology-research-access#webpage"
},
"headline": "Community-Based Oncology Trials to Improve Access and Expand Clinical Trial Site Networks | Fortrea Insights",
"description": "Explore how community-based oncology trials and the integration of community and regional sites are improving access to oncology clinical trials and expanding research reach. Learn how expanding clinical trial site networks in oncology supports diversity and equity in oncology clinical trials by bringing studies closer to patients. Explore how integrating community sites in clinical trials helps reduce patient burden, improve participation, and enhance overall trial accessibility. Learn how oncology clinical trial site solutions enable better patient access and strengthen oncology research access across underserved populations. By focusing on community engagement, site expansion, and equitable access, organizations can improve inclusion and drive more representative oncology clinical trial outcomes.",
"image": {
"@type": "ImageObject",
"url": "https://www.fortrea.com/sites/default/files/2025-08/community-trial-sites-oncology-access.jpg"
},
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2025-08-18",
"dateModified": "2025-08-18",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2025-08/community-trial-sites-oncology-access.pdf",
"encodingFormat": "application/pdf"
}
}
]
}